This article is from the WebMD News Archive
Feel Attractive, Have Better Sex?
Nov. 11, 2005 -- Call it the feeling-frumpy-or-fine phenomenon of sex and aging for women.
A new study shows that a woman's sex life may be richer if she thinks she's at least as attractive as she was 10 years earlier.
But if she thinks her glory days, in terms of attractiveness, are over, some aspects of her sex life might have faded as well.
"This study points out that women's body image was a significant predictor of their specific sexual functioning," researcher Patricia Bartholow Koch, PhD, tells WebMD.
Koch is an associate professor of biobehavioral health and women's studies at Pennsylvania State University.
The study recently appears in The Journal of Sex Research.
Heyday Over?
Koch and colleagues studied about 300 heterosexual women for a decade. The women were 35-55 years old. Most were white and college educated.
The women took surveys about their sex lives. They were also asked if they were more, less, or as attractive as a decade ago.
No matter how young or old the women were, they tended to report having been more attractive 10 years earlier. That sense of faded attractiveness was linked to less frequent sex and a drop in sexual desire.
"Women definitely receive messages in the culture that as they age they're less attractive and that can be interpreted as less sexual as well," Koch says. Unrealistic standards of attractiveness in the media are one such influence, she says.
Better With Age
Some women were exceptions. They reported being just as attractive as 10 years earlier. A few said they had become more attractive with time.
Those women reported increases in sex, sexual enjoyment, and sexual desire, says Koch.
The study focused on body image. Many women were critical of their bodies. However, some said age had brought more confidence, which made them feel more attractive.
Sexual Satisfaction Rated High
The vast majority of the women -- about 70% -- reported being satisfied with their sex lives, no matter how attractive they felt.
How does that square with the other findings? Researchers and medical professionals "may be placing too great of an emphasis on specific physiological reactions," Koch says.
For example, she says some women don't rate intense orgasms as being crucial for sexual satisfaction.
Women vary in their sexual priorities, and those priorities may shift over time and with different relationships, says Koch. She stresses that she's not saying that women don't care about sexual desire, arousal, and orgasm.
"It seems that they look more at the overall sexual experience," Koch says. "Some of the things that we don't usually measure -- such as intimacy, communication, [and] affection ... are qualities that they use to evaluate their sexual experience, as well as some of the physiological responses that researchers and medical professionals tend to focus more on."
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

